These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3796554)

  • 21. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary C-peptide: a useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood.
    de Beaufort CE; den Boer NC; Bruining GJ; Eilers GA; van Strik R; Weterings T
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():552-9. PubMed ID: 3069047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [C-peptide in type I diabetics].
    Perusicová J; Skachová J
    Vnitr Lek; 1986 Jun; 32(6):581-6. PubMed ID: 3739249
    [No Abstract]   [Full Text] [Related]  

  • 27. Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.
    Yoo HJ; Hartling SG; Binder C
    Korean J Intern Med; 1987 Jul; 2(2):196-200. PubMed ID: 3154831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine C-peptide, beta-cell function, and insulin requirement.
    Rappaport EB; Ulstrom RA; Etzwiler DD; Fife D; Hedlund BE; Steffes MW
    Am J Dis Child; 1980 Dec; 134(12):1129-33. PubMed ID: 7004175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methodological aspects on C-peptide measurements.
    Ludvigsson J
    Acta Med Scand Suppl; 1983; 671():53-9. PubMed ID: 6576623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The message for MODY.
    Hitman GA
    Diabet Med; 2011 Sep; 28(9):1009. PubMed ID: 21843300
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urinalysis of school children for the screening of juvenile diabetes mellitus (for 3 consecutive years in a single area) and C-peptide secretory capacity during 50g glucose loading].
    Mano T; Fujita H
    Horumon To Rinsho; 1977 Sep; 25(9):964-73. PubMed ID: 923121
    [No Abstract]   [Full Text] [Related]  

  • 32. [Application of artificial endocrine pancreas. - Improvement in insulin secretory ability and normalization of metabolic and endocrine disorders in diabetic subjects].
    Kawamori R; Shichiri M
    Horumon To Rinsho; 1982 Jul; 30(7):667-70. PubMed ID: 7127862
    [No Abstract]   [Full Text] [Related]  

  • 33. C-peptide an adequate endpoint in type 1 diabetes.
    Ludvigsson J
    Diabetes Metab Res Rev; 2009 Nov; 25(8):691-3. PubMed ID: 19877135
    [No Abstract]   [Full Text] [Related]  

  • 34. Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications.
    Zerbini G; Mangili R; Luzi L
    Diabet Med; 1999 Dec; 16(12):1048. PubMed ID: 10656236
    [No Abstract]   [Full Text] [Related]  

  • 35. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
    Besser RE; Ludvigsson J; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabetes Care; 2011 Mar; 34(3):607-9. PubMed ID: 21285386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Peptide and 24-Hour Urinary C-Peptide as Markers to Help Classify Types of Childhood Diabetes.
    Levitt Katz LE
    Horm Res Paediatr; 2015; 84(1):62-4. PubMed ID: 26045021
    [No Abstract]   [Full Text] [Related]  

  • 37. C-peptide: should we be testing this routinely in the Type 1 diabetes clinic?
    Huda MS; Hitman GA
    Diabet Med; 2015 Oct; 32(10):1259-60. PubMed ID: 26387579
    [No Abstract]   [Full Text] [Related]  

  • 38. [C-peptide (CPR)].
    Matsuda K; Oka Y
    Nihon Rinsho; 1999 Dec; 57 Suppl():313-6. PubMed ID: 10778126
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical significance of C-peptide.
    Rubenstein AH; Gonen B
    Adv Exp Med Biol; 1979; 124():15-28. PubMed ID: 506831
    [No Abstract]   [Full Text] [Related]  

  • 40. CD3-antibody therapy in new-onset type 1 diabetes mellitus.
    Haller MJ; Schatz DA
    N Engl J Med; 2005 Nov; 353(19):2086-7; author reply 2086-7. PubMed ID: 16282188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.